Condition
Subarachnoid Hemorrhage (SAH)
Total Trials
7
Recruiting
1
Active
1
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
14.3%
1 terminated out of 7 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
80% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed4
Recruiting1
Terminated1
Unknown1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06646484RecruitingPrimary
Interest of Impedancemetry in Monitoring Hydration and Hyponatremia During Subarachnoid Hemorrhages
NCT01593267Not ApplicableUnknown
Barrow Ruptured Aneurysm Trial
NCT03761654CompletedPrimary
Detection of Myocardial Dysfunction in Non-severe Subarachnoid Hemorrhage (WFNS 1-2) Using Speckle-tracking Echocardiography (STRAIN)
NCT01585311TerminatedPrimary
Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)
NCT02172703Not ApplicableCompleted
Non-invasive Brain Pressure Monitoring After Trauma or Hemorrhage
NCT00954551CompletedPrimary
Serum Procalcitonin
NCT00248690Not ApplicableCompletedPrimary
ICP Versus Intracranial Compliance Guided Management in SAH
Showing all 7 trials